
    
      Migraine patients according to International Headache Society criteria will be allocated
      randomly into two treatment arms. One group will receive active rTMS and another group will
      receive sham rTMS for treatment phase (5 sessions). Assessment will be made at baseline,
      month 1, month 2 and month 3 post-treatment.
    
  